je.st
news
Tag: biotech
Premarket Biotech Digest: Cancer Facts, Progenics' Relistor, Roche On Biotech Bubble
2015-09-16 15:08:07| Biotech - Topix.net
There are going to be about 1,658,370 new cancer cases in 2015. This figure excludes noninvasive, in situ cancers, and others that do not need to be reported.
Tags: cancer
facts
digest
bubble
The Nasdaq Biotech Index Rules the Roost
2015-09-15 22:23:25| Biotech - Topix.net
Times are a-changin'a and you only need to look at how the age expectancy of men and women continues to climb year after year. This has undoubtedly led to an increase in demand for additional and better-improved drugs to combat the ills of the day.
Tags: index
rules
nasdaq
biotech
Biotech 'bubble' pushes midsize buys out of reach: Roche CEO
2015-09-15 21:23:12| Biotech - Topix.net
The biotechnology sector is in a "bubble", pushing prices for medium-sized companies with experimental drugs in late-stage development out of reach, the chief executive of drugmaker Roche ( "I think this bubble will burst at some point," Severin Schwan told Reuters in an interview during a visit to London. The Swiss company continues to screen for promising acquisitions but the price of potential targets was now "far, far away" from fundamental value, he said.
Tags: reach
ceo
bubble
biotech
Premarket Biotech Digest: Pot Smokers Beware, Celgene Pullback, Baker Bros Back Aquinox
2015-09-15 19:14:05| Biotech - Topix.net
Does pot smoking lead to diabetes? Well, the consensus opinion has long been that it doesn't. In fact, marijuana helps glycemic control.
PharmaCyte Biotech Discusses Major Milestones Ahead of Phase 2b Clinical Trial in Pancreatic Cancer
2015-09-15 15:58:58| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , discussed today some of the major "milestone" tasks that must be completed to begin its Phase 2b clinical trial in pancreatic cancer. The trial will test the effectiveness and safety of PharmaCyte Biotech's pancreatic cancer treatment.
Sites : [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] next »